Skip to content
Screener

Absci Corporation ABSI Total Liabilities & Equity

Total Liabilities & Equity at other companies

Schrodinger logo
SchrodingerSDGR
$640.39M-7.0%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$1.21B-6.9%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$763.95M+34.1%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$1.31B-6.7%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$329.68M-21.9%
Assembly Biosciences logo
Assembly BiosciencesASMB
$235.51M+138%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.41B+235%
Enterprise value$1.4B+279%
P/S765.8×+664×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Absci Corporation’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:24 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001672688-26-000088
(In thousands, except for share and per share data)March 31, 2026December 31, 2025
STOCKHOLDERS' EQUITY
Preferred stock
Common stock1515
Additional paid-in capital826,035813,627
Accumulated deficit(654,383)(624,784)
Accumulated other comprehensive income304591
TOTAL STOCKHOLDERS' EQUITY171,971189,449
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$195,593$216,297

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Absci Corporation's total liabilities & equity?
Absci Corporation (ABSI) reported total liabilities & equity of $195.59M in Q1 2026.
How has Absci Corporation's total liabilities & equity changed year-over-year?
Absci Corporation's total liabilities & equity decreased by 15.9% year-over-year, from $232.45M to $195.59M.
What is the long-term trend for Absci Corporation's total liabilities & equity?
Over 5 years (2020 to 2025), Absci Corporation's total liabilities & equity has grown at a 19.6% compound annual growth rate (CAGR), from $88.57M to $216.3M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Absci Corporation's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude